Global PTCA Coronary Drug Eluting Balloons Market Insights and Forecast to 2031

Report ID: 1564326 | Published Date: Jan 2025 | No. of Page: 95 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 PTCA Coronary Drug Eluting Balloons Product Introduction
    1.2 Market by Type
        1.2.1 Global PTCA Coronary Drug Eluting Balloons Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 DEB Balloon
        1.2.3 Standard Balloon
    1.3 Market by Application
        1.3.1 Global PTCA Coronary Drug Eluting Balloons Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Small Vessel Disease
        1.3.3 Bifurcation Lesions
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global PTCA Coronary Drug Eluting Balloons Sales Estimates and Forecasts 2017-2028
    2.2 Global PTCA Coronary Drug Eluting Balloons Revenue Estimates and Forecasts 2017-2028
    2.3 Global PTCA Coronary Drug Eluting Balloons Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global PTCA Coronary Drug Eluting Balloons Sales by Region
        2.4.1 Global PTCA Coronary Drug Eluting Balloons Sales by Region (2017-2022)
        2.4.2 Global Sales PTCA Coronary Drug Eluting Balloons by Region (2023-2028)
    2.5 Global PTCA Coronary Drug Eluting Balloons Revenue by Region
        2.5.1 Global PTCA Coronary Drug Eluting Balloons Revenue by Region (2017-2022)
        2.5.2 Global PTCA Coronary Drug Eluting Balloons Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global PTCA Coronary Drug Eluting Balloons Sales by Manufacturers
        3.1.1 Global Top PTCA Coronary Drug Eluting Balloons Manufacturers by Sales (2017-2022)
        3.1.2 Global PTCA Coronary Drug Eluting Balloons Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of PTCA Coronary Drug Eluting Balloons in 2021
    3.2 Global PTCA Coronary Drug Eluting Balloons Revenue by Manufacturers
        3.2.1 Global PTCA Coronary Drug Eluting Balloons Revenue by Manufacturers (2017-2022)
        3.2.2 Global PTCA Coronary Drug Eluting Balloons Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by PTCA Coronary Drug Eluting Balloons Revenue in 2021
    3.3 Global PTCA Coronary Drug Eluting Balloons Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global PTCA Coronary Drug Eluting Balloons Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global PTCA Coronary Drug Eluting Balloons Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global PTCA Coronary Drug Eluting Balloons Sales by Type
        4.1.1 Global PTCA Coronary Drug Eluting Balloons Historical Sales by Type (2017-2022)
        4.1.2 Global PTCA Coronary Drug Eluting Balloons Forecasted Sales by Type (2023-2028)
        4.1.3 Global PTCA Coronary Drug Eluting Balloons Sales Market Share by Type (2017-2028)
    4.2 Global PTCA Coronary Drug Eluting Balloons Revenue by Type
        4.2.1 Global PTCA Coronary Drug Eluting Balloons Historical Revenue by Type (2017-2022)
        4.2.2 Global PTCA Coronary Drug Eluting Balloons Forecasted Revenue by Type (2023-2028)
        4.2.3 Global PTCA Coronary Drug Eluting Balloons Revenue Market Share by Type (2017-2028)
    4.3 Global PTCA Coronary Drug Eluting Balloons Price by Type
        4.3.1 Global PTCA Coronary Drug Eluting Balloons Price by Type (2017-2022)
        4.3.2 Global PTCA Coronary Drug Eluting Balloons Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global PTCA Coronary Drug Eluting Balloons Sales by Application
        5.1.1 Global PTCA Coronary Drug Eluting Balloons Historical Sales by Application (2017-2022)
        5.1.2 Global PTCA Coronary Drug Eluting Balloons Forecasted Sales by Application (2023-2028)
        5.1.3 Global PTCA Coronary Drug Eluting Balloons Sales Market Share by Application (2017-2028)
    5.2 Global PTCA Coronary Drug Eluting Balloons Revenue by Application
        5.2.1 Global PTCA Coronary Drug Eluting Balloons Historical Revenue by Application (2017-2022)
        5.2.2 Global PTCA Coronary Drug Eluting Balloons Forecasted Revenue by Application (2023-2028)
        5.2.3 Global PTCA Coronary Drug Eluting Balloons Revenue Market Share by Application (2017-2028)
    5.3 Global PTCA Coronary Drug Eluting Balloons Price by Application
        5.3.1 Global PTCA Coronary Drug Eluting Balloons Price by Application (2017-2022)
        5.3.2 Global PTCA Coronary Drug Eluting Balloons Price Forecast by Application (2023-2028)
6 North America
    6.1 North America PTCA Coronary Drug Eluting Balloons Market Size by Type
        6.1.1 North America PTCA Coronary Drug Eluting Balloons Sales by Type (2017-2028)
        6.1.2 North America PTCA Coronary Drug Eluting Balloons Revenue by Type (2017-2028)
    6.2 North America PTCA Coronary Drug Eluting Balloons Market Size by Application
        6.2.1 North America PTCA Coronary Drug Eluting Balloons Sales by Application (2017-2028)
        6.2.2 North America PTCA Coronary Drug Eluting Balloons Revenue by Application (2017-2028)
    6.3 North America PTCA Coronary Drug Eluting Balloons Market Size by Country
        6.3.1 North America PTCA Coronary Drug Eluting Balloons Sales by Country (2017-2028)
        6.3.2 North America PTCA Coronary Drug Eluting Balloons Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe PTCA Coronary Drug Eluting Balloons Market Size by Type
        7.1.1 Europe PTCA Coronary Drug Eluting Balloons Sales by Type (2017-2028)
        7.1.2 Europe PTCA Coronary Drug Eluting Balloons Revenue by Type (2017-2028)
    7.2 Europe PTCA Coronary Drug Eluting Balloons Market Size by Application
        7.2.1 Europe PTCA Coronary Drug Eluting Balloons Sales by Application (2017-2028)
        7.2.2 Europe PTCA Coronary Drug Eluting Balloons Revenue by Application (2017-2028)
    7.3 Europe PTCA Coronary Drug Eluting Balloons Market Size by Country
        7.3.1 Europe PTCA Coronary Drug Eluting Balloons Sales by Country (2017-2028)
        7.3.2 Europe PTCA Coronary Drug Eluting Balloons Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific PTCA Coronary Drug Eluting Balloons Market Size by Type
        8.1.1 Asia Pacific PTCA Coronary Drug Eluting Balloons Sales by Type (2017-2028)
        8.1.2 Asia Pacific PTCA Coronary Drug Eluting Balloons Revenue by Type (2017-2028)
    8.2 Asia Pacific PTCA Coronary Drug Eluting Balloons Market Size by Application
        8.2.1 Asia Pacific PTCA Coronary Drug Eluting Balloons Sales by Application (2017-2028)
        8.2.2 Asia Pacific PTCA Coronary Drug Eluting Balloons Revenue by Application (2017-2028)
    8.3 Asia Pacific PTCA Coronary Drug Eluting Balloons Market Size by Region
        8.3.1 Asia Pacific PTCA Coronary Drug Eluting Balloons Sales by Region (2017-2028)
        8.3.2 Asia Pacific PTCA Coronary Drug Eluting Balloons Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America PTCA Coronary Drug Eluting Balloons Market Size by Type
        9.1.1 Latin America PTCA Coronary Drug Eluting Balloons Sales by Type (2017-2028)
        9.1.2 Latin America PTCA Coronary Drug Eluting Balloons Revenue by Type (2017-2028)
    9.2 Latin America PTCA Coronary Drug Eluting Balloons Market Size by Application
        9.2.1 Latin America PTCA Coronary Drug Eluting Balloons Sales by Application (2017-2028)
        9.2.2 Latin America PTCA Coronary Drug Eluting Balloons Revenue by Application (2017-2028)
    9.3 Latin America PTCA Coronary Drug Eluting Balloons Market Size by Country
        9.3.1 Latin America PTCA Coronary Drug Eluting Balloons Sales by Country (2017-2028)
        9.3.2 Latin America PTCA Coronary Drug Eluting Balloons Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa PTCA Coronary Drug Eluting Balloons Market Size by Type
        10.1.1 Middle East and Africa PTCA Coronary Drug Eluting Balloons Sales by Type (2017-2028)
        10.1.2 Middle East and Africa PTCA Coronary Drug Eluting Balloons Revenue by Type (2017-2028)
    10.2 Middle East and Africa PTCA Coronary Drug Eluting Balloons Market Size by Application
        10.2.1 Middle East and Africa PTCA Coronary Drug Eluting Balloons Sales by Application (2017-2028)
        10.2.2 Middle East and Africa PTCA Coronary Drug Eluting Balloons Revenue by Application (2017-2028)
    10.3 Middle East and Africa PTCA Coronary Drug Eluting Balloons Market Size by Country
        10.3.1 Middle East and Africa PTCA Coronary Drug Eluting Balloons Sales by Country (2017-2028)
        10.3.2 Middle East and Africa PTCA Coronary Drug Eluting Balloons Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 B.Braun
        11.1.1 B.Braun Corporation Information
        11.1.2 B.Braun Overview
        11.1.3 B.Braun PTCA Coronary Drug Eluting Balloons Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 B.Braun PTCA Coronary Drug Eluting Balloons Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 B.Braun Recent Developments
    11.2 Spectranetics
        11.2.1 Spectranetics Corporation Information
        11.2.2 Spectranetics Overview
        11.2.3 Spectranetics PTCA Coronary Drug Eluting Balloons Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Spectranetics PTCA Coronary Drug Eluting Balloons Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Spectranetics Recent Developments
    11.3 Concept Medical
        11.3.1 Concept Medical Corporation Information
        11.3.2 Concept Medical Overview
        11.3.3 Concept Medical PTCA Coronary Drug Eluting Balloons Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Concept Medical PTCA Coronary Drug Eluting Balloons Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Concept Medical Recent Developments
    11.4 Eurocor
        11.4.1 Eurocor Corporation Information
        11.4.2 Eurocor Overview
        11.4.3 Eurocor PTCA Coronary Drug Eluting Balloons Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Eurocor PTCA Coronary Drug Eluting Balloons Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Eurocor Recent Developments
    11.5 Lifetech
        11.5.1 Lifetech Corporation Information
        11.5.2 Lifetech Overview
        11.5.3 Lifetech PTCA Coronary Drug Eluting Balloons Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Lifetech PTCA Coronary Drug Eluting Balloons Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Lifetech Recent Developments
    11.6 Maxcor
        11.6.1 Maxcor Corporation Information
        11.6.2 Maxcor Overview
        11.6.3 Maxcor PTCA Coronary Drug Eluting Balloons Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Maxcor PTCA Coronary Drug Eluting Balloons Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Maxcor Recent Developments
    11.7 Micell
        11.7.1 Micell Corporation Information
        11.7.2 Micell Overview
        11.7.3 Micell PTCA Coronary Drug Eluting Balloons Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Micell PTCA Coronary Drug Eluting Balloons Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Micell Recent Developments
    11.8 Qualimed
        11.8.1 Qualimed Corporation Information
        11.8.2 Qualimed Overview
        11.8.3 Qualimed PTCA Coronary Drug Eluting Balloons Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Qualimed PTCA Coronary Drug Eluting Balloons Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Qualimed Recent Developments
    11.9 Acrostak
        11.9.1 Acrostak Corporation Information
        11.9.2 Acrostak Overview
        11.9.3 Acrostak PTCA Coronary Drug Eluting Balloons Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Acrostak PTCA Coronary Drug Eluting Balloons Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Acrostak Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 PTCA Coronary Drug Eluting Balloons Industry Chain Analysis
    12.2 PTCA Coronary Drug Eluting Balloons Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 PTCA Coronary Drug Eluting Balloons Production Mode & Process
    12.4 PTCA Coronary Drug Eluting Balloons Sales and Marketing
        12.4.1 PTCA Coronary Drug Eluting Balloons Sales Channels
        12.4.2 PTCA Coronary Drug Eluting Balloons Distributors
    12.5 PTCA Coronary Drug Eluting Balloons Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 PTCA Coronary Drug Eluting Balloons Industry Trends
    13.2 PTCA Coronary Drug Eluting Balloons Market Drivers
    13.3 PTCA Coronary Drug Eluting Balloons Market Challenges
    13.4 PTCA Coronary Drug Eluting Balloons Market Restraints
14 Key Findings in The Global PTCA Coronary Drug Eluting Balloons Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global PTCA Coronary Drug Eluting Balloons Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of DEB Balloon
    Table 3. Major Manufacturers of Standard Balloon
    Table 4. Global PTCA Coronary Drug Eluting Balloons Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global PTCA Coronary Drug Eluting Balloons Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global PTCA Coronary Drug Eluting Balloons Sales by Region (2017-2022) & (K Units)
    Table 7. Global PTCA Coronary Drug Eluting Balloons Sales Market Share by Region (2017-2022)
    Table 8. Global PTCA Coronary Drug Eluting Balloons Sales by Region (2023-2028) & (K Units)
    Table 9. Global PTCA Coronary Drug Eluting Balloons Sales Market Share by Region (2023-2028)
    Table 10. Global PTCA Coronary Drug Eluting Balloons Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global PTCA Coronary Drug Eluting Balloons Revenue Market Share by Region (2017-2022)
    Table 12. Global PTCA Coronary Drug Eluting Balloons Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global PTCA Coronary Drug Eluting Balloons Revenue Market Share by Region (2023-2028)
    Table 14. Global PTCA Coronary Drug Eluting Balloons Sales by Manufacturers (2017-2022) & (K Units)
    Table 15. Global PTCA Coronary Drug Eluting Balloons Sales Share by Manufacturers (2017-2022)
    Table 16. Global PTCA Coronary Drug Eluting Balloons Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global PTCA Coronary Drug Eluting Balloons Revenue Share by Manufacturers (2017-2022)
    Table 18. PTCA Coronary Drug Eluting Balloons Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 19. Global PTCA Coronary Drug Eluting Balloons Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global PTCA Coronary Drug Eluting Balloons by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PTCA Coronary Drug Eluting Balloons as of 2021)
    Table 21. PTCA Coronary Drug Eluting Balloons Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers PTCA Coronary Drug Eluting Balloons Product Offered
    Table 23. Date of Manufacturers Enter into PTCA Coronary Drug Eluting Balloons Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global PTCA Coronary Drug Eluting Balloons Sales by Type (2017-2022) & (K Units)
    Table 26. Global PTCA Coronary Drug Eluting Balloons Sales by Type (2023-2028) & (K Units)
    Table 27. Global PTCA Coronary Drug Eluting Balloons Sales Share by Type (2017-2022)
    Table 28. Global PTCA Coronary Drug Eluting Balloons Sales Share by Type (2023-2028)
    Table 29. Global PTCA Coronary Drug Eluting Balloons Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global PTCA Coronary Drug Eluting Balloons Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global PTCA Coronary Drug Eluting Balloons Revenue Share by Type (2017-2022)
    Table 32. Global PTCA Coronary Drug Eluting Balloons Revenue Share by Type (2023-2028)
    Table 33. PTCA Coronary Drug Eluting Balloons Price by Type (2017-2022) & (USD/Unit)
    Table 34. Global PTCA Coronary Drug Eluting Balloons Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 35. Global PTCA Coronary Drug Eluting Balloons Sales by Application (2017-2022) & (K Units)
    Table 36. Global PTCA Coronary Drug Eluting Balloons Sales by Application (2023-2028) & (K Units)
    Table 37. Global PTCA Coronary Drug Eluting Balloons Sales Share by Application (2017-2022)
    Table 38. Global PTCA Coronary Drug Eluting Balloons Sales Share by Application (2023-2028)
    Table 39. Global PTCA Coronary Drug Eluting Balloons Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global PTCA Coronary Drug Eluting Balloons Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global PTCA Coronary Drug Eluting Balloons Revenue Share by Application (2017-2022)
    Table 42. Global PTCA Coronary Drug Eluting Balloons Revenue Share by Application (2023-2028)
    Table 43. PTCA Coronary Drug Eluting Balloons Price by Application (2017-2022) & (USD/Unit)
    Table 44. Global PTCA Coronary Drug Eluting Balloons Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 45. North America PTCA Coronary Drug Eluting Balloons Sales by Type (2017-2022) & (K Units)
    Table 46. North America PTCA Coronary Drug Eluting Balloons Sales by Type (2023-2028) & (K Units)
    Table 47. North America PTCA Coronary Drug Eluting Balloons Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America PTCA Coronary Drug Eluting Balloons Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America PTCA Coronary Drug Eluting Balloons Sales by Application (2017-2022) & (K Units)
    Table 50. North America PTCA Coronary Drug Eluting Balloons Sales by Application (2023-2028) & (K Units)
    Table 51. North America PTCA Coronary Drug Eluting Balloons Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America PTCA Coronary Drug Eluting Balloons Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America PTCA Coronary Drug Eluting Balloons Sales by Country (2017-2022) & (K Units)
    Table 54. North America PTCA Coronary Drug Eluting Balloons Sales by Country (2023-2028) & (K Units)
    Table 55. North America PTCA Coronary Drug Eluting Balloons Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America PTCA Coronary Drug Eluting Balloons Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe PTCA Coronary Drug Eluting Balloons Sales by Type (2017-2022) & (K Units)
    Table 58. Europe PTCA Coronary Drug Eluting Balloons Sales by Type (2023-2028) & (K Units)
    Table 59. Europe PTCA Coronary Drug Eluting Balloons Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe PTCA Coronary Drug Eluting Balloons Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe PTCA Coronary Drug Eluting Balloons Sales by Application (2017-2022) & (K Units)
    Table 62. Europe PTCA Coronary Drug Eluting Balloons Sales by Application (2023-2028) & (K Units)
    Table 63. Europe PTCA Coronary Drug Eluting Balloons Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe PTCA Coronary Drug Eluting Balloons Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe PTCA Coronary Drug Eluting Balloons Sales by Country (2017-2022) & (K Units)
    Table 66. Europe PTCA Coronary Drug Eluting Balloons Sales by Country (2023-2028) & (K Units)
    Table 67. Europe PTCA Coronary Drug Eluting Balloons Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe PTCA Coronary Drug Eluting Balloons Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific PTCA Coronary Drug Eluting Balloons Sales by Type (2017-2022) & (K Units)
    Table 70. Asia Pacific PTCA Coronary Drug Eluting Balloons Sales by Type (2023-2028) & (K Units)
    Table 71. Asia Pacific PTCA Coronary Drug Eluting Balloons Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific PTCA Coronary Drug Eluting Balloons Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific PTCA Coronary Drug Eluting Balloons Sales by Application (2017-2022) & (K Units)
    Table 74. Asia Pacific PTCA Coronary Drug Eluting Balloons Sales by Application (2023-2028) & (K Units)
    Table 75. Asia Pacific PTCA Coronary Drug Eluting Balloons Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific PTCA Coronary Drug Eluting Balloons Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific PTCA Coronary Drug Eluting Balloons Sales by Region (2017-2022) & (K Units)
    Table 78. Asia Pacific PTCA Coronary Drug Eluting Balloons Sales by Region (2023-2028) & (K Units)
    Table 79. Asia Pacific PTCA Coronary Drug Eluting Balloons Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific PTCA Coronary Drug Eluting Balloons Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America PTCA Coronary Drug Eluting Balloons Sales by Type (2017-2022) & (K Units)
    Table 82. Latin America PTCA Coronary Drug Eluting Balloons Sales by Type (2023-2028) & (K Units)
    Table 83. Latin America PTCA Coronary Drug Eluting Balloons Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America PTCA Coronary Drug Eluting Balloons Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America PTCA Coronary Drug Eluting Balloons Sales by Application (2017-2022) & (K Units)
    Table 86. Latin America PTCA Coronary Drug Eluting Balloons Sales by Application (2023-2028) & (K Units)
    Table 87. Latin America PTCA Coronary Drug Eluting Balloons Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America PTCA Coronary Drug Eluting Balloons Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America PTCA Coronary Drug Eluting Balloons Sales by Country (2017-2022) & (K Units)
    Table 90. Latin America PTCA Coronary Drug Eluting Balloons Sales by Country (2023-2028) & (K Units)
    Table 91. Latin America PTCA Coronary Drug Eluting Balloons Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America PTCA Coronary Drug Eluting Balloons Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa PTCA Coronary Drug Eluting Balloons Sales by Type (2017-2022) & (K Units)
    Table 94. Middle East and Africa PTCA Coronary Drug Eluting Balloons Sales by Type (2023-2028) & (K Units)
    Table 95. Middle East and Africa PTCA Coronary Drug Eluting Balloons Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa PTCA Coronary Drug Eluting Balloons Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa PTCA Coronary Drug Eluting Balloons Sales by Application (2017-2022) & (K Units)
    Table 98. Middle East and Africa PTCA Coronary Drug Eluting Balloons Sales by Application (2023-2028) & (K Units)
    Table 99. Middle East and Africa PTCA Coronary Drug Eluting Balloons Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa PTCA Coronary Drug Eluting Balloons Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa PTCA Coronary Drug Eluting Balloons Sales by Country (2017-2022) & (K Units)
    Table 102. Middle East and Africa PTCA Coronary Drug Eluting Balloons Sales by Country (2023-2028) & (K Units)
    Table 103. Middle East and Africa PTCA Coronary Drug Eluting Balloons Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa PTCA Coronary Drug Eluting Balloons Revenue by Country (2023-2028) & (US$ Million)
    Table 105. B.Braun Corporation Information
    Table 106. B.Braun Description and Major Businesses
    Table 107. B.Braun PTCA Coronary Drug Eluting Balloons Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 108. B.Braun PTCA Coronary Drug Eluting Balloons Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. B.Braun Recent Developments
    Table 110. Spectranetics Corporation Information
    Table 111. Spectranetics Description and Major Businesses
    Table 112. Spectranetics PTCA Coronary Drug Eluting Balloons Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 113. Spectranetics PTCA Coronary Drug Eluting Balloons Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Spectranetics Recent Developments
    Table 115. Concept Medical Corporation Information
    Table 116. Concept Medical Description and Major Businesses
    Table 117. Concept Medical PTCA Coronary Drug Eluting Balloons Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 118. Concept Medical PTCA Coronary Drug Eluting Balloons Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Concept Medical Recent Developments
    Table 120. Eurocor Corporation Information
    Table 121. Eurocor Description and Major Businesses
    Table 122. Eurocor PTCA Coronary Drug Eluting Balloons Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 123. Eurocor PTCA Coronary Drug Eluting Balloons Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Eurocor Recent Developments
    Table 125. Lifetech Corporation Information
    Table 126. Lifetech Description and Major Businesses
    Table 127. Lifetech PTCA Coronary Drug Eluting Balloons Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 128. Lifetech PTCA Coronary Drug Eluting Balloons Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Lifetech Recent Developments
    Table 130. Maxcor Corporation Information
    Table 131. Maxcor Description and Major Businesses
    Table 132. Maxcor PTCA Coronary Drug Eluting Balloons Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 133. Maxcor PTCA Coronary Drug Eluting Balloons Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Maxcor Recent Developments
    Table 135. Micell Corporation Information
    Table 136. Micell Description and Major Businesses
    Table 137. Micell PTCA Coronary Drug Eluting Balloons Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 138. Micell PTCA Coronary Drug Eluting Balloons Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Micell Recent Developments
    Table 140. Qualimed Corporation Information
    Table 141. Qualimed Description and Major Businesses
    Table 142. Qualimed PTCA Coronary Drug Eluting Balloons Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 143. Qualimed PTCA Coronary Drug Eluting Balloons Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Qualimed Recent Developments
    Table 145. Acrostak Corporation Information
    Table 146. Acrostak Description and Major Businesses
    Table 147. Acrostak PTCA Coronary Drug Eluting Balloons Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 148. Acrostak PTCA Coronary Drug Eluting Balloons Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Acrostak Recent Developments
    Table 150. Key Raw Materials Lists
    Table 151. Raw Materials Key Suppliers Lists
    Table 152. PTCA Coronary Drug Eluting Balloons Distributors List
    Table 153. PTCA Coronary Drug Eluting Balloons Customers List
    Table 154. PTCA Coronary Drug Eluting Balloons Market Trends
    Table 155. PTCA Coronary Drug Eluting Balloons Market Drivers
    Table 156. PTCA Coronary Drug Eluting Balloons Market Challenges
    Table 157. PTCA Coronary Drug Eluting Balloons Market Restraints
    Table 158. Research Programs/Design for This Report
    Table 159. Key Data Information from Secondary Sources
    Table 160. Key Data Information from Primary Sources
List of Figures
    Figure 1. PTCA Coronary Drug Eluting Balloons Product Picture
    Figure 3. Global PTCA Coronary Drug Eluting Balloons Market Share by Type in 2021 & 2028
    Figure 3. DEB Balloon Product Picture
    Figure 4. Standard Balloon Product Picture
    Figure 5. Global PTCA Coronary Drug Eluting Balloons Market Share by Application in 2021 & 2028
    Figure 6. Small Vessel Disease
    Figure 7. Bifurcation Lesions
    Figure 8. Others
    Figure 9. PTCA Coronary Drug Eluting Balloons Report Years Considered
    Figure 10. Global PTCA Coronary Drug Eluting Balloons Sales 2017-2028 (K Units)
    Figure 11. Global PTCA Coronary Drug Eluting Balloons Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global PTCA Coronary Drug Eluting Balloons Revenue 2017-2028 (US$ Million)
    Figure 13. Global PTCA Coronary Drug Eluting Balloons Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global PTCA Coronary Drug Eluting Balloons Sales Market Share by Region (2017-2022)
    Figure 15. Global PTCA Coronary Drug Eluting Balloons Sales Market Share by Region (2023-2028)
    Figure 16. North America PTCA Coronary Drug Eluting Balloons Sales YoY (2017-2028) & (K Units)
    Figure 17. North America PTCA Coronary Drug Eluting Balloons Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe PTCA Coronary Drug Eluting Balloons Sales YoY (2017-2028) & (K Units)
    Figure 19. Europe PTCA Coronary Drug Eluting Balloons Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific PTCA Coronary Drug Eluting Balloons Sales YoY (2017-2028) & (K Units)
    Figure 21. Asia-Pacific PTCA Coronary Drug Eluting Balloons Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America PTCA Coronary Drug Eluting Balloons Sales YoY (2017-2028) & (K Units)
    Figure 23. Latin America PTCA Coronary Drug Eluting Balloons Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa PTCA Coronary Drug Eluting Balloons Sales YoY (2017-2028) & (K Units)
    Figure 25. Middle East & Africa PTCA Coronary Drug Eluting Balloons Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The PTCA Coronary Drug Eluting Balloons Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of PTCA Coronary Drug Eluting Balloons in the World: Market Share by PTCA Coronary Drug Eluting Balloons Revenue in 2021
    Figure 28. Global PTCA Coronary Drug Eluting Balloons Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global PTCA Coronary Drug Eluting Balloons Sales Market Share by Type (2017-2028)
    Figure 30. Global PTCA Coronary Drug Eluting Balloons Revenue Market Share by Type (2017-2028)
    Figure 31. Global PTCA Coronary Drug Eluting Balloons Sales Market Share by Application (2017-2028)
    Figure 32. Global PTCA Coronary Drug Eluting Balloons Revenue Market Share by Application (2017-2028)
    Figure 33. North America PTCA Coronary Drug Eluting Balloons Sales Market Share by Type (2017-2028)
    Figure 34. North America PTCA Coronary Drug Eluting Balloons Revenue Market Share by Type (2017-2028)
    Figure 35. North America PTCA Coronary Drug Eluting Balloons Sales Market Share by Application (2017-2028)
    Figure 36. North America PTCA Coronary Drug Eluting Balloons Revenue Market Share by Application (2017-2028)
    Figure 37. North America PTCA Coronary Drug Eluting Balloons Sales Share by Country (2017-2028)
    Figure 38. North America PTCA Coronary Drug Eluting Balloons Revenue Share by Country (2017-2028)
    Figure 39. U.S. PTCA Coronary Drug Eluting Balloons Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada PTCA Coronary Drug Eluting Balloons Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe PTCA Coronary Drug Eluting Balloons Sales Market Share by Type (2017-2028)
    Figure 42. Europe PTCA Coronary Drug Eluting Balloons Revenue Market Share by Type (2017-2028)
    Figure 43. Europe PTCA Coronary Drug Eluting Balloons Sales Market Share by Application (2017-2028)
    Figure 44. Europe PTCA Coronary Drug Eluting Balloons Revenue Market Share by Application (2017-2028)
    Figure 45. Europe PTCA Coronary Drug Eluting Balloons Sales Share by Country (2017-2028)
    Figure 46. Europe PTCA Coronary Drug Eluting Balloons Revenue Share by Country (2017-2028)
    Figure 47. Germany PTCA Coronary Drug Eluting Balloons Revenue (2017-2028) & (US$ Million)
    Figure 48. France PTCA Coronary Drug Eluting Balloons Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. PTCA Coronary Drug Eluting Balloons Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy PTCA Coronary Drug Eluting Balloons Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia PTCA Coronary Drug Eluting Balloons Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific PTCA Coronary Drug Eluting Balloons Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific PTCA Coronary Drug Eluting Balloons Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific PTCA Coronary Drug Eluting Balloons Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific PTCA Coronary Drug Eluting Balloons Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific PTCA Coronary Drug Eluting Balloons Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific PTCA Coronary Drug Eluting Balloons Revenue Share by Region (2017-2028)
    Figure 58. China PTCA Coronary Drug Eluting Balloons Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan PTCA Coronary Drug Eluting Balloons Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea PTCA Coronary Drug Eluting Balloons Revenue (2017-2028) & (US$ Million)
    Figure 61. India PTCA Coronary Drug Eluting Balloons Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia PTCA Coronary Drug Eluting Balloons Revenue (2017-2028) & (US$ Million)
    Figure 63. Taiwan PTCA Coronary Drug Eluting Balloons Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia PTCA Coronary Drug Eluting Balloons Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand PTCA Coronary Drug Eluting Balloons Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia PTCA Coronary Drug Eluting Balloons Revenue (2017-2028) & (US$ Million)
    Figure 67. Philippines PTCA Coronary Drug Eluting Balloons Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America PTCA Coronary Drug Eluting Balloons Sales Market Share by Type (2017-2028)
    Figure 69. Latin America PTCA Coronary Drug Eluting Balloons Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America PTCA Coronary Drug Eluting Balloons Sales Market Share by Application (2017-2028)
    Figure 71. Latin America PTCA Coronary Drug Eluting Balloons Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America PTCA Coronary Drug Eluting Balloons Sales Share by Country (2017-2028)
    Figure 73. Latin America PTCA Coronary Drug Eluting Balloons Revenue Share by Country (2017-2028)
    Figure 74. Mexico PTCA Coronary Drug Eluting Balloons Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil PTCA Coronary Drug Eluting Balloons Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina PTCA Coronary Drug Eluting Balloons Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa PTCA Coronary Drug Eluting Balloons Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa PTCA Coronary Drug Eluting Balloons Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa PTCA Coronary Drug Eluting Balloons Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa PTCA Coronary Drug Eluting Balloons Revenue Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa PTCA Coronary Drug Eluting Balloons Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa PTCA Coronary Drug Eluting Balloons Revenue Share by Country (2017-2028)
    Figure 83. Turkey PTCA Coronary Drug Eluting Balloons Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia PTCA Coronary Drug Eluting Balloons Revenue (2017-2028) & (US$ Million)
    Figure 85. UAE PTCA Coronary Drug Eluting Balloons Revenue (2017-2028) & (US$ Million)
    Figure 86. PTCA Coronary Drug Eluting Balloons Value Chain
    Figure 87. PTCA Coronary Drug Eluting Balloons Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
B.Braun
Spectranetics
Concept Medical
Eurocor
Lifetech
Maxcor
Micell
Qualimed
Acrostak
Frequently Asked Questions
PTCA Coronary Drug Eluting Balloons report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
PTCA Coronary Drug Eluting Balloons report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
PTCA Coronary Drug Eluting Balloons report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Pulse Jet Bag Filter

Pulse Jet Bag Filter market is segmented by Type and by Application. Players, stakeholders, and o ... Read More

Push-Pull Golf Cart

Push-Pull Golf Cart market is segmented by Type and by Application. Players, stakeholders, and ot ... Read More

Radial Piston Pump

Radial Piston Pump market is segmented by Type and by Application. Players, stakeholders, and oth ... Read More